Literature DB >> 484646

Obtaining drug exposure histories during pregnancy.

T W Bodendorfer, G G Briggs, J E Gunning.   

Abstract

One hundred fifty-three pregnant patients were included in this study to verify the amount of drugs ingested during their pregnancies. The results demonstrate that, unknown to the physician, pregnant patients take a variety of pharmacologic agents. The patient's medical record is considered grossly inadequate in documenting an accurate assessment of a patient's exposure to drugs taken during pregnancy. Drug histories were obtained utilizing the hospital pharmacist drug history interview and home diary. Validity testing of the pharmacist's drug history and of the medical record history was not performed. The patient's compliance for utilizing the home diary for drugs or chemicals taken during their pregnancy was 83% (127 patients). It was shown that the usual methods of drug history documentation will identify only 30% of the actual drug exposure to the fetus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 484646     DOI: 10.1016/0002-9378(79)90437-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Investigating drug use in pregnancy. Methodological problems and perspectives.

Authors:  L T De Jong-van den Berg; P B Van den Berg; F M Haaijer-Ruskamp; M N Dukes; H Wesseling
Journal:  Pharm Weekbl Sci       Date:  1991-02-22

2.  Drug use in pregnancy: an overview of epidemiological (drug utilization) studies.

Authors:  M Bonati; R Bortolus; F Marchetti; M Romero; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Information on drug use in pregnancy from the Viewpoint Regional Drug Information Centre.

Authors:  O Kasilo; M Romero; M Bonati; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 4.  Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.

Authors:  Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Drug use in pregnancy: a comparative appraisal of data collecting methods.

Authors:  L T de Jong-van den Berg; C M Waardenburg; F M Haaijer-Ruskamp; M N Dukes; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Handling of risk-bearing drugs during pregnancy. Do we choose less risky alternatives?

Authors:  L T De Jong-Van den Berg; P B Van den Berg; F M Haaijer-Ruskamp; M N Dukes; H Wesseling
Journal:  Pharm Weekbl Sci       Date:  1992-04-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.